BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18552237)

  • 21. Biocompatibility parameters in in-vitro simulated automated versus continuous ambulatory peritoneal dialysis.
    Fusshoeller A; Baehr J; Tiemann B; Grabensee B; Plum J
    Clin Nephrol; 2005 Sep; 64(3):214-20. PubMed ID: 16175946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
    Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
    Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution.
    García H; Hernández-Jaras J; Cruz Mdel C; Agramunt I; Calvo C; Cerrillo V
    Perit Dial Int; 2003; 23(4):375-80. PubMed ID: 12968846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization.
    Zhou X; Chen H; Shi Y; Li J; Ma X; Du L; Hu Y; Tao M; Zhong Q; Yan D; Zhuang S; Liu N
    Front Immunol; 2023; 14():1137332. PubMed ID: 36911746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TGF-beta-induced gene product, betaig-h3: its biological implications in peritoneal dialysis.
    Park SH; Choi SY; Kim MH; Oh EJ; Ryu HM; Kim CD; Kim IS; Kim YL
    Nephrol Dial Transplant; 2008 Jan; 23(1):126-35. PubMed ID: 17704110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation.
    le Poole CY; Welten AG; ter Wee PM; Paauw NJ; Djorai AN; Valentijn RM; Beelen RH; van den Born J; van Ittersum FJ
    Perit Dial Int; 2012; 32(3):305-15. PubMed ID: 22045100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
    Krediet RT
    Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
    Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
    Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
    Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
    Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
    Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
    Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells.
    Chang JM; Lin SP; Lai YH; Chen HC
    Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions.
    Opatrna S; Lysak D; Trefil L; Parker C; Topley N
    Perit Dial Int; 2012; 32(1):37-44. PubMed ID: 22302924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
    Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
    Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation.
    Kang DH; Hong YS; Lim HJ; Choi JH; Han DS; Yoon KI
    Perit Dial Int; 1999; 19(3):221-30. PubMed ID: 10433158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution?
    Duman S; Günal AI; Sen S; Asçi G; Ozkahya M; Terzioglu E; Akçiçek F; Atabay G
    Perit Dial Int; 2001; 21(2):219-24. PubMed ID: 11330572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of dialysis duration, peritoneal transport parameters, and gender on effluent CA125 concentration in patients on peritoneal dialysis.
    Mojahedi MJ; Hami M; Shakeri MT; Hekmat R
    Iran J Kidney Dis; 2007 Oct; 1(2):78-81. PubMed ID: 19363281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients.
    Visser CE; Brouwer-Steenbergen JJ; Betjes MG; Koomen GC; Beelen RH; Krediet RT
    Nephrol Dial Transplant; 1995; 10(1):64-9. PubMed ID: 7724031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.